COMPUGEN Stock Profile

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:4em;padding-top: 25px;;'>CO</div>


15 / 100

Odds of Distress

Analyze Filter   Check how we calculate scores
Equity ratings for COMPUGEN are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting November 27, 2019 and ending today February 25, 2020. Click here to learn more.


Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. The company was incorporated in 1993 and is headquartered in Holon, Israel. COMPUGEN operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 89 people. more on COMPUGEN
CEOAnat CohenDayagView All
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Few selected profitability drivers of COMPUGEN representing accounts that assess its ability to generate profits relative to its revenue, operating costs, and shareholders' equity
Net Income
Operating Income
Net Income Per Employee
Operating Margin
Gross Margin
Profit Margin
COMPUGEN (CGEN) is traded on Tel Aviv Stock Exchange in Israel and employs 89 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 2.31 B. COMPUGEN operates under Healthcare sector and is part of Biotechnology industry. The entity has 62.39 M outstanding shares. COMPUGEN has accumulated about 47.64 M in cash with (21.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Check COMPUGEN Probability Of Bankruptcy

COMPUGEN Stock Price Odds Analysis

Odds Below 3148.0HorizonTargetOdds Above 3148.0
98.72%30 days 3,148 1.28%
Based on normal probability distribution, the odds of COMPUGEN to move above current price in 30 days from now is about 1.28 (This COMPUGEN probability density function shows the probability of COMPUGEN Stock to fall within a particular range of prices over 30 days) .

COMPUGEN Income Statement Over Time

Direct Expenses    Net Income    Revenues    

COMPUGEN Stock Against Markets

Did you try this?

Run Portfolio Rebalancing Now


Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Module

COMPUGEN Corporate Directors

Joshua Shemer Independent External Director
Michal Preminger Director
Dov Hershberg Director
Continue to Trending Equities. Please also try Price Ceiling Movement module to calculate and plot price ceiling movement for different equity instruments.
Company logos by clearbit